HOTH News and Press, Hoth Therapeutics Inc. From 01/11/21

Hoth Therapeutics to Initiate IND Enabling Studies of HT-001 Treatment for Cancer Patients PR Newswire NEW YORK , Jan. 11, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced an agreement with Charles River ...

Hoth Therapeutics (HOTH) has entered into a definitive securities purchase agreement in connection with a private placement to institutional investors.The Company expects to receive gross proceeds of ~$5M, not including any proceeds from exercise of warrants. Under the agreement, th...

Hoth Therapeutics Announces Private Placement of Equity Priced At-The-Market Under Nasdaq Rules Definitive Agreement for $5.0 Million in Gross Proceeds PR Newswire NEW YORK , Jan. 5, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharm...

Bionano Genomics (BNGO) -22%.Stable Road Acquisition (SRAC) -12% Momentus updates on 2021 mission, merger with SRAC remains on track to close in Q1.ViewRay (VRAY) -12% after prices equity offering at $4.85.AirNet Technology (ANTE) -11%.TransEnterix (TRXC) -13%.Hall of...

Hoth Therapeutics (HOTH) jumps 15% premarket in reaction to the announcement that its has entered into a Non-Exclusive Commercial Evaluation License Agreement with the U.S. Army Medical Research and Development Command for a new molecular entity ((NME)) developed by the Walter ...

Hoth Therapeutics Announces Licensing Agreement and Collaboration with U.S. Army Medical Research and Development Command (USAMRDC) for Treating Multi-Drug Resistant Bacterial Lung Infections License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Re...

Gainers: Hoth Therapeutics (HOTH) +49%. Bionano Genomics (BNGO) +38%. Clearside Biomedical (CLSD) +17%. Regional Health Properties (RHE) +14%. Ampio Pharmaceuticals (AMPE) +13%.Losers: Histogen (HSTO) -26%. Novan (NOVN) -22%. ORIC Pharmaceuticals (ORIC) -14%. DermTech (DMTK) -12%. T...

Biopharmaceutical company Hoth Therapeutics (HOTH) has signed a production agreement for both GLP and GMP materials associated with HT-001 with Tergus Pharma for its novel cancer treatment. The update follows the recent news that Hoth has requested a Pre-Investigational New Drug ((IND)) meeti...

Ashford (AINC) +75%.PEDEVCO (PED) +62%.SGOCO (SGOC) +49%.Ebang International Holdings (EBON) +33%.Red Lion Hotels RLH +31% on being acquired by Sonesta.Canaan (CAN) +30%.AirNet Technology (ANTE) +25%.Hudson Capital HUSN +24% as FreightHub posts stellar Q3 results.Hoth Ther...

Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment PR Newswire NEW YORK , Dec. 31, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that it has signed a production agreement for both GLP ...